FindTrial
Sign In

Study on exocrine pancreatic autoantibodies and pancreatic functions in diabetic patients

Study on exocrine pancreatic autoantibodies and pancreatic functions in diabetic patients - Exocrine pancreatic antibodies in diabetes (EXP-DIABETES STUDY)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000020955
Enrollment
100
Registered
2016-02-10
Start date
2016-02-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Interventions

None listed

Sponsors

Okinaka Memorial Institute for Medical Research
Lead Sponsor
Department of Medicine, Showa University School of Medicine. Department of Endocrinology and Metabolism, Toranomon Hospital. Department of Medicine Saiseikai Central Hospital.
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Diabetic patient (including possible case)

Exclusion criteria

Exclusion criteria: heavy alcohol user, pancreatitis, diabetic nephropathy (stage 3 or more), diabetic ketoacidosis, pregnancy, hepatic cirrhosis, malignant tumor

Design outcomes

Primary

MeasureTime frame
Presence of autoantibodies against exocrine pancreas and pancreatic digestive dysfunctions in diabetic patients—

Secondary

MeasureTime frame
Blood glucose value, HbA1c, pancreatic enzyme (amylase, lipase, trypsin) levels, pancreatic tissue changes—

Countries

Japan

Contacts

Public ContactTetsuro Kobayashi

Okinaka Memorial Institute for Medical Research Division of Immunology and Molecular Medicine

tetsurou@yamanashi.ac.jp03-3588-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026